LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

SUPRIYA

NSEBSE
Supriya Lifescience Limited
Healthcare· Pharmaceuticals & Biotechnology· INE07RO01027· Scrip: 543434
ENहिन्दीગુજરાતીमराठी
697.00
7.70 (-1.09%)
29/4/2026, 3:28:56 pm
NSE
697.00
7.70
-1.09%
BSE
699.55
4.95
+0.00%
56262368474580704-2906-2508-2110-2012-1702-1604-2304-29
245 trading days · 1Y period
TODAY
Open704.70
High707.80
Low695.00
Prev Close704.70
Volume1.22L
Value₹8.5Cr
L: 695.00H: 707.80
52 WEEK
Low545.50
High832.40
53% of 52W range
Info
Face Value₹2
Listed2021-12-28
ISININE07RO01027
SeriesA
BSE Scrip543434

Key Metrics

1D
-1.09%
1W
+6.25%
1M
+19.31%
3M
-5.82%
6M
-3.55%
Valuation
Mkt Cap₹4917 Cr
Growth (QoQ)
Revenue+11.77%
PAT+1.37%
EPS+1.93%
Profitability
Dividend
Yield0.14%
Growth+25.00%
TTM Revenue
₹671 Cr
TTM EBITDA
₹256 Cr
TTM PAT
₹175 Cr
TTM EPS
₹21.66
Rev/Share
₹83.3

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr46 Cr93 Cr139 Cr186 Cr23-0323-0623-0923-1224-0324-0624-0924-124.83.53.03.74.65.55.75.8
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31186 Cr125 Cr68 Cr63 Cr47 Cr5.82
2024-09-30166 Cr107 Cr67 Cr62 Cr46 Cr5.71
2024-06-30161 Cr103 Cr64 Cr60 Cr45 Cr5.54
2024-03-31158 Cr107 Cr57 Cr53 Cr37 Cr4.59
2023-12-31140 Cr103 Cr44 Cr40 Cr30 Cr3.70
2023-09-30140 Cr113 Cr34 Cr30 Cr24 Cr2.97
2023-06-30132 Cr92 Cr47 Cr43 Cr29 Cr3.54
2023-03-31142 Cr91 Cr56 Cr53 Cr38 Cr4.75

Shareholding Pattern

CURRENT2026-03-31
68.3%PROMOTER
Promoter68.3%
FII5.2%
DII5.7%
Public31.7%
PROMOTER HOLDING TREND
68.3%24-0668.3%24-0968.3%24-1268.3%25-0368.3%25-0968.3%25-1268.3%26-03

Corporate Actions

Ex-DateTypePurpose
2025-09-04DividendDividend - Re 1 Per Share
2024-09-20DividendAnnual General Meeting/Dividend - Rs 0.80 Per Share
2023-09-15DividendAnnual General Meeting/Dividend - Re 0.60 Per Share
2022-09-01DividendAnnual General Meeting/Dividend - Re 0.60 Per Share

Earnings Transcripts

Supriya Lifescience Limited has informed the Exchange about Link of Recording of the Earnings Call f...
13 Nov 2025NSE1K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
12 Nov 2025NSE29K chars
Read →
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201...
9 Nov 2025NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
13 Aug 2025NSE28K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
27 May 2025NSE26K chars
Read →
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, the details of the Analyst/Investor Meetin...
17 Mar 2025NSE3K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
24 Jan 2025NSE28K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
7 Nov 2023NSE29K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
3 Aug 2023NSE25K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
27 May 2023NSE29K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
14 Feb 2023NSE27K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...
17 Nov 2022NSE40K chars
Read →
In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure ...
11 Nov 2022NSE2K chars
Read →
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,...
11 Nov 2022NSE30K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
3 Nov 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
30 Aug 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
25 Aug 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
24 Aug 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...
23 Aug 2022NSE56K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Recording of Analysts/Institutional Inve...
16 Aug 2022NSE2K chars
Read →

Price History

DateOpenHighLowCloseVolume
2026-04-29704.70707.80695.00698.251.22L
2026-04-28709.00717.45700.00704.702.15L
2026-04-27660.00710.00655.00704.4510.57L
2026-04-24663.50668.90632.05642.855.78L
2026-04-23657.00669.00650.10663.101.66L
2026-04-22621.75660.00620.00656.004.04L
2026-04-21624.75629.90618.00620.7585,207
2026-04-20647.00651.00615.10619.802.25L
2026-04-17635.00665.60619.35638.502.00L
2026-04-16638.45644.90625.35628.3090,947
2026-04-15646.00653.20631.30635.351.11L
2026-04-13617.00642.40617.00637.5584,800
2026-04-10634.95645.00631.65638.7557,243
2026-04-09628.00640.15624.65628.5571,467
2026-04-08642.25642.25621.90636.951.01L
2026-04-07618.90618.90603.20610.7062,834
2026-04-02590.10615.00583.95612.2096,974
2026-04-01569.95613.05569.95601.002.09L
2026-03-27593.00609.70579.65587.552.68L
2026-03-25574.80605.95574.10592.602.25L
2026-03-24562.30579.00545.50564.353.29L
2026-03-20582.00592.50582.00584.2095,765
2026-03-19576.00587.50576.00579.901.43L
2026-03-18576.00598.90576.00589.251.64L
2026-03-17580.00595.95570.20574.501.40L
2026-03-16573.00588.00565.00573.801.75L
2026-03-13589.65605.00574.55576.902.63L
2026-03-12596.55603.90581.90585.802.30L
2026-03-11610.00614.00595.00596.5574,387
2026-03-10590.00606.95585.80604.801.06L

Frequently Asked Questions

About

Supriya Lifescience Limited, established in 1987, is a prominent Indian generic pharmaceutical company based in Mumbai, specializing in the research, development, manufacturing, and sale of bulk drugs and active pharmaceutical ingredients (APIs) for various therapeutic areas including antihistamines, anti-allergic, and anti-asthmatic treatments. The company caters to the global pharmaceutical market through its focus on APIs and pharmaceutical chemicals, contributing significantly to the supply chain for generic medicines.

BOARD OF DIRECTORS